Home    Back

Target Gene/Pathway💬 Info on mouse-over

e.g. Sirolimus, Adalimumab, MAP2K

ABCDEFGH I JKLMNOPQRSTUVWXYZother

146 / 286 pathways

No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related		 KEGG GENES KEGG DRUG DrugBank Disease ID
1 Acute myeloid leukemia 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
2 Acute myeloid leukemia 💬
 [1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
3 Adherens junction 💬
 [2] EGFR, ERBB2 💬 D11772 💬 Tesevatinib [1] 67 💬
4 Adherens junction 💬
 [1] SRC 💬 D03252 💬 Bosutinib [2]  2 , 67 💬
5 Adipocytokine signaling pathway 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
6 Adipocytokine signaling pathway 💬
 [1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
7 Adipocytokine signaling pathway 💬
 [2] PRKAA1, PRKAA2 💬 D00944 💬 Metformin [21]  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
8 Adipocytokine signaling pathway 💬
 [2] PRKAA1, PRKAA2 💬 D04966 💬 Metformin [21]  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
9 Adrenergic signaling in cardiomyocytes 💬
 [3] ADRA1A, ADRA1B, ADRA1D 💬 D00608 💬 Doxazosin [2] 57, 67 💬
10 Adrenergic signaling in cardiomyocytes 💬
 [3] ADRA1A, ADRA1B, ADRA1D 💬 D07874 💬 Doxazosin [2] 57, 67 💬
11 Adrenergic signaling in cardiomyocytes 💬
 [1] ADRB1 💬 D00634 💬 Bisoprolol [3] 67, 86, 113 💬
12 Adrenergic signaling in cardiomyocytes 💬
 [1] ADRB1 💬 D02342 💬 Bisoprolol [3] 67, 86, 113 💬
13 Adrenergic signaling in cardiomyocytes 💬
 [1] AGTR1 💬 D00522 💬 Candesartan [2] 58, 67 💬
14 Adrenergic signaling in cardiomyocytes 💬
 [1] AGTR1 💬 D00522 💬 Candesartan cilexetil [1] 67 💬
15 Adrenergic signaling in cardiomyocytes 💬
 [1] AGTR1 💬 D00626 💬 Candesartan cilexetil [1] 67 💬
16 Adrenergic signaling in cardiomyocytes 💬
 [1] AGTR1 💬 D00357 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
17 Adrenergic signaling in cardiomyocytes 💬
 [1] AGTR1 💬 D08146 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
18 Adrenergic signaling in cardiomyocytes 💬
 [1] AGTR1 💬 D00627 💬 Telmisartan [2] 66, 67 💬
19 Adrenergic signaling in cardiomyocytes 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00615 💬 Amlodipine [4] 13, 51, 67, 298 💬
20 Adrenergic signaling in cardiomyocytes 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02914 💬 Amlodipine [4] 13, 51, 67, 298 💬
21 Adrenergic signaling in cardiomyocytes 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07450 💬 Amlodipine [4] 13, 51, 67, 298 💬
22 Adrenergic signaling in cardiomyocytes 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01173 💬 Cilnidipine [1] 67 💬
23 AGE-RAGE signaling pathway in diabetic complications 💬
 [1] AGTR1 💬 D00522 💬 Candesartan [2] 58, 67 💬
24 AGE-RAGE signaling pathway in diabetic complications 💬
 [1] AGTR1 💬 D00522 💬 Candesartan cilexetil [1] 67 💬
25 AGE-RAGE signaling pathway in diabetic complications 💬
 [1] AGTR1 💬 D00626 💬 Candesartan cilexetil [1] 67 💬
26 AGE-RAGE signaling pathway in diabetic complications 💬
 [1] AGTR1 💬 D00357 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
27 AGE-RAGE signaling pathway in diabetic complications 💬
 [1] AGTR1 💬 D08146 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
28 AGE-RAGE signaling pathway in diabetic complications 💬
 [1] AGTR1 💬 D00627 💬 Telmisartan [2] 66, 67 💬
29 Aldosterone synthesis and secretion 💬
 [1] AGTR1 💬 D00522 💬 Candesartan [2] 58, 67 💬
30 Aldosterone synthesis and secretion 💬
 [1] AGTR1 💬 D00522 💬 Candesartan cilexetil [1] 67 💬
31 Aldosterone synthesis and secretion 💬
 [1] AGTR1 💬 D00626 💬 Candesartan cilexetil [1] 67 💬
32 Aldosterone synthesis and secretion 💬
 [1] AGTR1 💬 D00357 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
33 Aldosterone synthesis and secretion 💬
 [1] AGTR1 💬 D08146 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
34 Aldosterone synthesis and secretion 💬
 [1] AGTR1 💬 D00627 💬 Telmisartan [2] 66, 67 💬
35 Aldosterone synthesis and secretion 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00615 💬 Amlodipine [4] 13, 51, 67, 298 💬
36 Aldosterone synthesis and secretion 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02914 💬 Amlodipine [4] 13, 51, 67, 298 💬
37 Aldosterone synthesis and secretion 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07450 💬 Amlodipine [4] 13, 51, 67, 298 💬
38 Aldosterone synthesis and secretion 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01173 💬 Cilnidipine [1] 67 💬
39 Aldosterone-regulated sodium reabsorption 💬
 [1] NR3C2 💬 D00443 💬 Spironolactone [7] 58, 67, 86, 113, 210, 218, 225 💬
40 Alzheimer disease 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00615 💬 Amlodipine [4] 13, 51, 67, 298 💬
41 Alzheimer disease 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02914 💬 Amlodipine [4] 13, 51, 67, 298 💬
42 Alzheimer disease 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07450 💬 Amlodipine [4] 13, 51, 67, 298 💬
43 Alzheimer disease 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01173 💬 Cilnidipine [1] 67 💬
44 Alzheimer disease 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
45 Alzheimer disease 💬
 [1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
46 Amphetamine addiction 💬
 [2] CACNA1C, CACNA1D 💬 D00615 💬 Amlodipine [4] 13, 51, 67, 298 💬
47 Amphetamine addiction 💬
 [2] CACNA1C, CACNA1D 💬 D02914 💬 Amlodipine [4] 13, 51, 67, 298 💬
48 Amphetamine addiction 💬
 [2] CACNA1C, CACNA1D 💬 D07450 💬 Amlodipine [4] 13, 51, 67, 298 💬
49 Amphetamine addiction 💬
 [2] CACNA1C, CACNA1D 💬 D01173 💬 Cilnidipine [1] 67 💬
50 AMPK signaling pathway 💬
 [1] ADRA1A 💬 D00608 💬 Doxazosin [2] 57, 67 💬
51 AMPK signaling pathway 💬
 [1] ADRA1A 💬 D07874 💬 Doxazosin [2] 57, 67 💬
52 AMPK signaling pathway 💬
 [1] HMGCR 💬 D00893 💬 Pravastatin [9] 13, 46, 49, 67, 79, 96, 164, 265, 333 💬
53 AMPK signaling pathway 💬
 [1] HMGCR 💬 D08410 💬 Pravastatin [9] 13, 46, 49, 67, 79, 96, 164, 265, 333 💬
54 AMPK signaling pathway 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
55 AMPK signaling pathway 💬
 [1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
56 AMPK signaling pathway 💬
 [1] PPARG 💬 D00945 💬 Pioglitazone [17]  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
57 AMPK signaling pathway 💬
 [1] PPARG 💬 D08378 💬 Pioglitazone [17]  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
58 AMPK signaling pathway 💬
 [2] PRKAA1, PRKAA2 💬 D00944 💬 Metformin [21]  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
59 AMPK signaling pathway 💬
 [2] PRKAA1, PRKAA2 💬 D04966 💬 Metformin [21]  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
60 Amyotrophic lateral sclerosis 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
61 Amyotrophic lateral sclerosis 💬
 [1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
62 Apelin signaling pathway 💬
 [1] AGTR1 💬 D00522 💬 Candesartan [2] 58, 67 💬
63 Apelin signaling pathway 💬
 [1] AGTR1 💬 D00522 💬 Candesartan cilexetil [1] 67 💬
64 Apelin signaling pathway 💬
 [1] AGTR1 💬 D00626 💬 Candesartan cilexetil [1] 67 💬
65 Apelin signaling pathway 💬
 [1] AGTR1 💬 D00357 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
66 Apelin signaling pathway 💬
 [1] AGTR1 💬 D08146 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
67 Apelin signaling pathway 💬
 [1] AGTR1 💬 D00627 💬 Telmisartan [2] 66, 67 💬
68 Apelin signaling pathway 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
69 Apelin signaling pathway 💬
 [1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
70 Apelin signaling pathway 💬
 [2] PRKAA1, PRKAA2 💬 D00944 💬 Metformin [21]  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
71 Apelin signaling pathway 💬
 [2] PRKAA1, PRKAA2 💬 D04966 💬 Metformin [21]  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
72 Arrhythmogenic right ventricular cardiomyopathy 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00615 💬 Amlodipine [4] 13, 51, 67, 298 💬
73 Arrhythmogenic right ventricular cardiomyopathy 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02914 💬 Amlodipine [4] 13, 51, 67, 298 💬
74 Arrhythmogenic right ventricular cardiomyopathy 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07450 💬 Amlodipine [4] 13, 51, 67, 298 💬
75 Arrhythmogenic right ventricular cardiomyopathy 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01173 💬 Cilnidipine [1] 67 💬
76 Autophagy - animal 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
77 Autophagy - animal 💬
 [1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
78 Autophagy - animal 💬
 [2] PRKAA1, PRKAA2 💬 D00944 💬 Metformin [21]  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
79 Autophagy - animal 💬
 [2] PRKAA1, PRKAA2 💬 D04966 💬 Metformin [21]  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
80 Autophagy - other 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
81 Autophagy - other 💬
 [1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
82 Axon guidance 💬
 [2] ABL1, SRC 💬 D03252 💬 Bosutinib [2]  2 , 67 💬
83 Axon guidance 💬
 [1] EPHB4 💬 D11772 💬 Tesevatinib [1] 67 💬
84 Bacterial invasion of epithelial cells 💬
 [1] SRC 💬 D03252 💬 Bosutinib [2]  2 , 67 💬
85 beta-Alanine metabolism 💬
 [1] AOC3 💬 D08044 💬 Hydralazine [1] 67 💬
86 Bile secretion 💬
 [1] HMGCR 💬 D00893 💬 Pravastatin [9] 13, 46, 49, 67, 79, 96, 164, 265, 333 💬
87 Bile secretion 💬
 [1] HMGCR 💬 D08410 💬 Pravastatin [9] 13, 46, 49, 67, 79, 96, 164, 265, 333 💬
88 Bile secretion 💬
 [1] NR1H4 💬 D00734 💬 Ursodeoxycholic acid [13]  6 ,  8 , 20, 67, 84, 93, 94, 95, 96, 97, 234, 296, 299 💬
89 Bladder cancer 💬
 [2] EGFR, ERBB2 💬 D11772 💬 Tesevatinib [1] 67 💬
90 Bladder cancer 💬
 [1] SRC 💬 D03252 💬 Bosutinib [2]  2 , 67 💬
91 Breast cancer 💬
 [3] EGFR, ERBB2, FLT4 💬 D11772 💬 Tesevatinib [1] 67 💬
92 Breast cancer 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
93 Breast cancer 💬
 [1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
94 C-type lectin receptor signaling pathway 💬
 [1] SRC 💬 D03252 💬 Bosutinib [2]  2 , 67 💬
95 Calcium signaling pathway 💬
 [3] ADRA1A, ADRA1B, ADRA1D 💬 D00608 💬 Doxazosin [2] 57, 67 💬
96 Calcium signaling pathway 💬
 [3] ADRA1A, ADRA1B, ADRA1D 💬 D07874 💬 Doxazosin [2] 57, 67 💬
97 Calcium signaling pathway 💬
 [1] ADRB1 💬 D00634 💬 Bisoprolol [3] 67, 86, 113 💬
98 Calcium signaling pathway 💬
 [1] ADRB1 💬 D02342 💬 Bisoprolol [3] 67, 86, 113 💬
99 Calcium signaling pathway 💬
 [1] AGTR1 💬 D00522 💬 Candesartan [2] 58, 67 💬
100 Calcium signaling pathway 💬
 [1] AGTR1 💬 D00522 💬 Candesartan cilexetil [1] 67 💬
101 Calcium signaling pathway 💬
 [1] AGTR1 💬 D00626 💬 Candesartan cilexetil [1] 67 💬
102 Calcium signaling pathway 💬
 [1] AGTR1 💬 D00357 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
103 Calcium signaling pathway 💬
 [1] AGTR1 💬 D08146 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
104 Calcium signaling pathway 💬
 [1] AGTR1 💬 D00627 💬 Telmisartan [2] 66, 67 💬
105 Calcium signaling pathway 💬
 [5] CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01173 💬 Cilnidipine [1] 67 💬
106 Calcium signaling pathway 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00615 💬 Amlodipine [4] 13, 51, 67, 298 💬
107 Calcium signaling pathway 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02914 💬 Amlodipine [4] 13, 51, 67, 298 💬
108 Calcium signaling pathway 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07450 💬 Amlodipine [4] 13, 51, 67, 298 💬
109 Calcium signaling pathway 💬
 [4] EGFR, ERBB2, FLT4, KDR 💬 D11772 💬 Tesevatinib [1] 67 💬
110 cAMP signaling pathway 💬
 [1] ADRB1 💬 D00634 💬 Bisoprolol [3] 67, 86, 113 💬
111 cAMP signaling pathway 💬
 [1] ADRB1 💬 D02342 💬 Bisoprolol [3] 67, 86, 113 💬
112 cAMP signaling pathway 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00615 💬 Amlodipine [4] 13, 51, 67, 298 💬
113 cAMP signaling pathway 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02914 💬 Amlodipine [4] 13, 51, 67, 298 💬
114 cAMP signaling pathway 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07450 💬 Amlodipine [4] 13, 51, 67, 298 💬
115 cAMP signaling pathway 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01173 💬 Cilnidipine [1] 67 💬
116 cAMP signaling pathway 💬
 [3] SSTR1, SSTR2, SSTR5 💬 D10147 💬 Pasireotide [3] 67, 74, 75 💬
117 cAMP signaling pathway 💬
 [3] SSTR1, SSTR2, SSTR5 💬 D07431 💬 Somatostatin [2] 67, 78 💬
118 cAMP signaling pathway 💬
 [1] SSTR2 💬 D00442 💬 Octreotide [7] 67, 75, 84, 85, 89, 193, 227 💬
119 cAMP signaling pathway 💬
 [1] SSTR2 💬 D06495 💬 Octreotide [7] 67, 75, 84, 85, 89, 193, 227 💬
120 Carbohydrate digestion and absorption 💬
 [1] CACNA1D 💬 D00615 💬 Amlodipine [4] 13, 51, 67, 298 💬
121 Carbohydrate digestion and absorption 💬
 [1] CACNA1D 💬 D02914 💬 Amlodipine [4] 13, 51, 67, 298 💬
122 Carbohydrate digestion and absorption 💬
 [1] CACNA1D 💬 D07450 💬 Amlodipine [4] 13, 51, 67, 298 💬
123 Carbohydrate digestion and absorption 💬
 [1] CACNA1D 💬 D01173 💬 Cilnidipine [1] 67 💬
124 Carbohydrate digestion and absorption 💬
 [2] TAS1R2, TAS1R3 💬 D02381 💬 Aspartame [5]  6 , 13, 67, 86, 230 💬
125 Cardiac muscle contraction 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00615 💬 Amlodipine [4] 13, 51, 67, 298 💬
126 Cardiac muscle contraction 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02914 💬 Amlodipine [4] 13, 51, 67, 298 💬
127 Cardiac muscle contraction 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07450 💬 Amlodipine [4] 13, 51, 67, 298 💬
128 Cardiac muscle contraction 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01173 💬 Cilnidipine [1] 67 💬
129 Cell cycle 💬
 [1] ABL1 💬 D03252 💬 Bosutinib [2]  2 , 67 💬
130 Cellular senescence 💬
 [1] CACNA1D 💬 D00615 💬 Amlodipine [4] 13, 51, 67, 298 💬
131 Cellular senescence 💬
 [1] CACNA1D 💬 D02914 💬 Amlodipine [4] 13, 51, 67, 298 💬
132 Cellular senescence 💬
 [1] CACNA1D 💬 D07450 💬 Amlodipine [4] 13, 51, 67, 298 💬
133 Cellular senescence 💬
 [1] CACNA1D 💬 D01173 💬 Cilnidipine [1] 67 💬
134 Cellular senescence 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
135 Cellular senescence 💬
 [1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
136 Central carbon metabolism in cancer 💬
 [2] EGFR, ERBB2 💬 D11772 💬 Tesevatinib [1] 67 💬
137 Central carbon metabolism in cancer 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
138 Central carbon metabolism in cancer 💬
 [1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
139 cGMP-PKG signaling pathway 💬
 [3] ADRA1A, ADRA1B, ADRA1D 💬 D00608 💬 Doxazosin [2] 57, 67 💬
140 cGMP-PKG signaling pathway 💬
 [3] ADRA1A, ADRA1B, ADRA1D 💬 D07874 💬 Doxazosin [2] 57, 67 💬
141 cGMP-PKG signaling pathway 💬
 [1] ADRB1 💬 D00634 💬 Bisoprolol [3] 67, 86, 113 💬
142 cGMP-PKG signaling pathway 💬
 [1] ADRB1 💬 D02342 💬 Bisoprolol [3] 67, 86, 113 💬
143 cGMP-PKG signaling pathway 💬
 [1] AGTR1 💬 D00522 💬 Candesartan [2] 58, 67 💬
144 cGMP-PKG signaling pathway 💬
 [1] AGTR1 💬 D00522 💬 Candesartan cilexetil [1] 67 💬
145 cGMP-PKG signaling pathway 💬
 [1] AGTR1 💬 D00626 💬 Candesartan cilexetil [1] 67 💬
146 cGMP-PKG signaling pathway 💬
 [1] AGTR1 💬 D00357 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
147 cGMP-PKG signaling pathway 💬
 [1] AGTR1 💬 D08146 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
148 cGMP-PKG signaling pathway 💬
 [1] AGTR1 💬 D00627 💬 Telmisartan [2] 66, 67 💬
149 cGMP-PKG signaling pathway 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00615 💬 Amlodipine [4] 13, 51, 67, 298 💬
150 cGMP-PKG signaling pathway 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02914 💬 Amlodipine [4] 13, 51, 67, 298 💬
151 cGMP-PKG signaling pathway 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07450 💬 Amlodipine [4] 13, 51, 67, 298 💬
152 cGMP-PKG signaling pathway 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01173 💬 Cilnidipine [1] 67 💬
153 Chagas disease 💬
 [1] ACE 💬 D08068 💬 Imidapril [1] 67 💬
154 Chagas disease 💬
 [1] ACE 💬 D00362 💬 Lisinopril [7] 19, 46, 49, 66, 67, 113, 222 💬
155 Chagas disease 💬
 [1] ACE 💬 D08131 💬 Lisinopril [7] 19, 46, 49, 66, 67, 113, 222 💬
156 Chagas disease 💬
 [1] ACE 💬 D00421 💬 Ramipril [7] 46, 49, 66, 67, 113, 218, 257 💬
157 Chemokine signaling pathway 💬
 [1] SRC 💬 D03252 💬 Bosutinib [2]  2 , 67 💬
158 Choline metabolism in cancer 💬
 [1] EGFR 💬 D11772 💬 Tesevatinib [1] 67 💬
159 Choline metabolism in cancer 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
160 Choline metabolism in cancer 💬
 [1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
161 Cholinergic synapse 💬
 [5] CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01173 💬 Cilnidipine [1] 67 💬
162 Cholinergic synapse 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00615 💬 Amlodipine [4] 13, 51, 67, 298 💬
163 Cholinergic synapse 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02914 💬 Amlodipine [4] 13, 51, 67, 298 💬
164 Cholinergic synapse 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07450 💬 Amlodipine [4] 13, 51, 67, 298 💬
165 Chronic myeloid leukemia 💬
 [1] ABL1 💬 D03252 💬 Bosutinib [2]  2 , 67 💬
166 Circadian entrainment 💬
 [2] CACNA1C, CACNA1D 💬 D00615 💬 Amlodipine [4] 13, 51, 67, 298 💬
167 Circadian entrainment 💬
 [2] CACNA1C, CACNA1D 💬 D02914 💬 Amlodipine [4] 13, 51, 67, 298 💬
168 Circadian entrainment 💬
 [2] CACNA1C, CACNA1D 💬 D07450 💬 Amlodipine [4] 13, 51, 67, 298 💬
169 Circadian entrainment 💬
 [2] CACNA1C, CACNA1D 💬 D01173 💬 Cilnidipine [1] 67 💬
170 Circadian rhythm 💬
 [2] PRKAA1, PRKAA2 💬 D00944 💬 Metformin [21]  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
171 Circadian rhythm 💬
 [2] PRKAA1, PRKAA2 💬 D04966 💬 Metformin [21]  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
172 Colorectal cancer 💬
 [1] EGFR 💬 D11772 💬 Tesevatinib [1] 67 💬
173 Colorectal cancer 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
174 Colorectal cancer 💬
 [1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
175 Coronavirus disease - COVID-19 💬
 [1] ACE 💬 D08068 💬 Imidapril [1] 67 💬
176 Coronavirus disease - COVID-19 💬
 [1] ACE 💬 D00362 💬 Lisinopril [7] 19, 46, 49, 66, 67, 113, 222 💬
177 Coronavirus disease - COVID-19 💬
 [1] ACE 💬 D08131 💬 Lisinopril [7] 19, 46, 49, 66, 67, 113, 222 💬
178 Coronavirus disease - COVID-19 💬
 [1] ACE 💬 D00421 💬 Ramipril [7] 46, 49, 66, 67, 113, 218, 257 💬
179 Coronavirus disease - COVID-19 💬
 [1] AGTR1 💬 D00522 💬 Candesartan [2] 58, 67 💬
180 Coronavirus disease - COVID-19 💬
 [1] AGTR1 💬 D00522 💬 Candesartan cilexetil [1] 67 💬
181 Coronavirus disease - COVID-19 💬
 [1] AGTR1 💬 D00626 💬 Candesartan cilexetil [1] 67 💬
182 Coronavirus disease - COVID-19 💬
 [1] AGTR1 💬 D00357 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
183 Coronavirus disease - COVID-19 💬
 [1] AGTR1 💬 D08146 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
184 Coronavirus disease - COVID-19 💬
 [1] AGTR1 💬 D00627 💬 Telmisartan [2] 66, 67 💬
185 Coronavirus disease - COVID-19 💬
 [1] EGFR 💬 D11772 💬 Tesevatinib [1] 67 💬
186 Cortisol synthesis and secretion 💬
 [1] AGTR1 💬 D00522 💬 Candesartan [2] 58, 67 💬
187 Cortisol synthesis and secretion 💬
 [1] AGTR1 💬 D00522 💬 Candesartan cilexetil [1] 67 💬
188 Cortisol synthesis and secretion 💬
 [1] AGTR1 💬 D00626 💬 Candesartan cilexetil [1] 67 💬
189 Cortisol synthesis and secretion 💬
 [1] AGTR1 💬 D00357 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
190 Cortisol synthesis and secretion 💬
 [1] AGTR1 💬 D08146 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
191 Cortisol synthesis and secretion 💬
 [1] AGTR1 💬 D00627 💬 Telmisartan [2] 66, 67 💬
192 Cortisol synthesis and secretion 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00615 💬 Amlodipine [4] 13, 51, 67, 298 💬
193 Cortisol synthesis and secretion 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02914 💬 Amlodipine [4] 13, 51, 67, 298 💬
194 Cortisol synthesis and secretion 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07450 💬 Amlodipine [4] 13, 51, 67, 298 💬
195 Cortisol synthesis and secretion 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01173 💬 Cilnidipine [1] 67 💬
196 Cushing syndrome 💬
 [1] AGTR1 💬 D00522 💬 Candesartan [2] 58, 67 💬
197 Cushing syndrome 💬
 [1] AGTR1 💬 D00522 💬 Candesartan cilexetil [1] 67 💬
198 Cushing syndrome 💬
 [1] AGTR1 💬 D00626 💬 Candesartan cilexetil [1] 67 💬
199 Cushing syndrome 💬
 [1] AGTR1 💬 D00357 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
200 Cushing syndrome 💬
 [1] AGTR1 💬 D08146 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
201 Cushing syndrome 💬
 [1] AGTR1 💬 D00627 💬 Telmisartan [2] 66, 67 💬
202 Cushing syndrome 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00615 💬 Amlodipine [4] 13, 51, 67, 298 💬
203 Cushing syndrome 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02914 💬 Amlodipine [4] 13, 51, 67, 298 💬
204 Cushing syndrome 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07450 💬 Amlodipine [4] 13, 51, 67, 298 💬
205 Cushing syndrome 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01173 💬 Cilnidipine [1] 67 💬
206 Cushing syndrome 💬
 [1] EGFR 💬 D11772 💬 Tesevatinib [1] 67 💬
207 Diabetic cardiomyopathy 💬
 [1] ACE 💬 D08068 💬 Imidapril [1] 67 💬
208 Diabetic cardiomyopathy 💬
 [1] ACE 💬 D00362 💬 Lisinopril [7] 19, 46, 49, 66, 67, 113, 222 💬
209 Diabetic cardiomyopathy 💬
 [1] ACE 💬 D08131 💬 Lisinopril [7] 19, 46, 49, 66, 67, 113, 222 💬
210 Diabetic cardiomyopathy 💬
 [1] ACE 💬 D00421 💬 Ramipril [7] 46, 49, 66, 67, 113, 218, 257 💬
211 Diabetic cardiomyopathy 💬
 [1] AGTR1 💬 D00522 💬 Candesartan [2] 58, 67 💬
212 Diabetic cardiomyopathy 💬
 [1] AGTR1 💬 D00522 💬 Candesartan cilexetil [1] 67 💬
213 Diabetic cardiomyopathy 💬
 [1] AGTR1 💬 D00626 💬 Candesartan cilexetil [1] 67 💬
214 Diabetic cardiomyopathy 💬
 [1] AGTR1 💬 D00357 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
215 Diabetic cardiomyopathy 💬
 [1] AGTR1 💬 D08146 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
216 Diabetic cardiomyopathy 💬
 [1] AGTR1 💬 D00627 💬 Telmisartan [2] 66, 67 💬
217 Diabetic cardiomyopathy 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
218 Diabetic cardiomyopathy 💬
 [1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
219 Dilated cardiomyopathy 💬
 [1] ADRB1 💬 D00634 💬 Bisoprolol [3] 67, 86, 113 💬
220 Dilated cardiomyopathy 💬
 [1] ADRB1 💬 D02342 💬 Bisoprolol [3] 67, 86, 113 💬
221 Dilated cardiomyopathy 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00615 💬 Amlodipine [4] 13, 51, 67, 298 💬
222 Dilated cardiomyopathy 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02914 💬 Amlodipine [4] 13, 51, 67, 298 💬
223 Dilated cardiomyopathy 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07450 💬 Amlodipine [4] 13, 51, 67, 298 💬
224 Dilated cardiomyopathy 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01173 💬 Cilnidipine [1] 67 💬
225 Dopaminergic synapse 💬
 [3] CACNA1B, CACNA1C, CACNA1D 💬 D01173 💬 Cilnidipine [1] 67 💬
226 Dopaminergic synapse 💬
 [2] CACNA1C, CACNA1D 💬 D00615 💬 Amlodipine [4] 13, 51, 67, 298 💬
227 Dopaminergic synapse 💬
 [2] CACNA1C, CACNA1D 💬 D02914 💬 Amlodipine [4] 13, 51, 67, 298 💬
228 Dopaminergic synapse 💬
 [2] CACNA1C, CACNA1D 💬 D07450 💬 Amlodipine [4] 13, 51, 67, 298 💬
229 EGFR tyrosine kinase inhibitor resistance 💬
 [3] EGFR, ERBB2, KDR 💬 D11772 💬 Tesevatinib [1] 67 💬
230 EGFR tyrosine kinase inhibitor resistance 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
231 EGFR tyrosine kinase inhibitor resistance 💬
 [1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
232 EGFR tyrosine kinase inhibitor resistance 💬
 [1] SRC 💬 D03252 💬 Bosutinib [2]  2 , 67 💬
233 Endocrine resistance 💬
 [2] EGFR, ERBB2 💬 D11772 💬 Tesevatinib [1] 67 💬
234 Endocrine resistance 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
235 Endocrine resistance 💬
 [1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
236 Endocrine resistance 💬
 [1] SRC 💬 D03252 💬 Bosutinib [2]  2 , 67 💬
237 Endocytosis 💬
 [1] EGFR 💬 D11772 💬 Tesevatinib [1] 67 💬
238 Endocytosis 💬
 [1] SRC 💬 D03252 💬 Bosutinib [2]  2 , 67 💬
239 Endometrial cancer 💬
 [2] EGFR, ERBB2 💬 D11772 💬 Tesevatinib [1] 67 💬
240 Epithelial cell signaling in Helicobacter pylori infection 💬
 [1] EGFR 💬 D11772 💬 Tesevatinib [1] 67 💬
241 Epithelial cell signaling in Helicobacter pylori infection 💬
 [1] SRC 💬 D03252 💬 Bosutinib [2]  2 , 67 💬
242 ErbB signaling pathway 💬
 [2] ABL1, SRC 💬 D03252 💬 Bosutinib [2]  2 , 67 💬
243 ErbB signaling pathway 💬
 [2] EGFR, ERBB2 💬 D11772 💬 Tesevatinib [1] 67 💬
244 ErbB signaling pathway 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
245 ErbB signaling pathway 💬
 [1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
246 Estrogen signaling pathway 💬
 [1] EGFR 💬 D11772 💬 Tesevatinib [1] 67 💬
247 Estrogen signaling pathway 💬
 [1] SRC 💬 D03252 💬 Bosutinib [2]  2 , 67 💬
248 Fluid shear stress and atherosclerosis 💬
 [1] KDR 💬 D11772 💬 Tesevatinib [1] 67 💬
249 Fluid shear stress and atherosclerosis 💬
 [2] PRKAA1, PRKAA2 💬 D00944 💬 Metformin [21]  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
250 Fluid shear stress and atherosclerosis 💬
 [2] PRKAA1, PRKAA2 💬 D04966 💬 Metformin [21]  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
251 Fluid shear stress and atherosclerosis 💬
 [1] SRC 💬 D03252 💬 Bosutinib [2]  2 , 67 💬
252 Focal adhesion 💬
 [4] EGFR, ERBB2, FLT4, KDR 💬 D11772 💬 Tesevatinib [1] 67 💬
253 Focal adhesion 💬
 [1] SRC 💬 D03252 💬 Bosutinib [2]  2 , 67 💬
254 FoxO signaling pathway 💬
 [1] EGFR 💬 D11772 💬 Tesevatinib [1] 67 💬
255 FoxO signaling pathway 💬
 [2] PRKAA1, PRKAA2 💬 D00944 💬 Metformin [21]  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
256 FoxO signaling pathway 💬
 [2] PRKAA1, PRKAA2 💬 D04966 💬 Metformin [21]  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
257 GABAergic synapse 💬
 [5] CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01173 💬 Cilnidipine [1] 67 💬
258 GABAergic synapse 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00615 💬 Amlodipine [4] 13, 51, 67, 298 💬
259 GABAergic synapse 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02914 💬 Amlodipine [4] 13, 51, 67, 298 💬
260 GABAergic synapse 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07450 💬 Amlodipine [4] 13, 51, 67, 298 💬
261 GABAergic synapse 💬
 [1] SRC 💬 D03252 💬 Bosutinib [2]  2 , 67 💬
262 Gap junction 💬
 [1] ADRB1 💬 D00634 💬 Bisoprolol [3] 67, 86, 113 💬
263 Gap junction 💬
 [1] ADRB1 💬 D02342 💬 Bisoprolol [3] 67, 86, 113 💬
264 Gap junction 💬
 [1] EGFR 💬 D11772 💬 Tesevatinib [1] 67 💬
265 Gap junction 💬
 [1] SRC 💬 D03252 💬 Bosutinib [2]  2 , 67 💬
266 Gastric acid secretion 💬
 [1] SSTR2 💬 D00442 💬 Octreotide [7] 67, 75, 84, 85, 89, 193, 227 💬
267 Gastric acid secretion 💬
 [1] SSTR2 💬 D06495 💬 Octreotide [7] 67, 75, 84, 85, 89, 193, 227 💬
268 Gastric acid secretion 💬
 [1] SSTR2 💬 D10147 💬 Pasireotide [3] 67, 74, 75 💬
269 Gastric acid secretion 💬
 [1] SSTR2 💬 D07431 💬 Somatostatin [2] 67, 78 💬
270 Gastric cancer 💬
 [2] EGFR, ERBB2 💬 D11772 💬 Tesevatinib [1] 67 💬
271 Gastric cancer 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
272 Gastric cancer 💬
 [1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
273 Glioma 💬
 [1] EGFR 💬 D11772 💬 Tesevatinib [1] 67 💬
274 Glioma 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
275 Glioma 💬
 [1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
276 Glucagon signaling pathway 💬
 [2] PRKAA1, PRKAA2 💬 D00944 💬 Metformin [21]  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
277 Glucagon signaling pathway 💬
 [2] PRKAA1, PRKAA2 💬 D04966 💬 Metformin [21]  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
278 Glutamatergic synapse 💬
 [2] CACNA1C, CACNA1D 💬 D00615 💬 Amlodipine [4] 13, 51, 67, 298 💬
279 Glutamatergic synapse 💬
 [2] CACNA1C, CACNA1D 💬 D02914 💬 Amlodipine [4] 13, 51, 67, 298 💬
280 Glutamatergic synapse 💬
 [2] CACNA1C, CACNA1D 💬 D07450 💬 Amlodipine [4] 13, 51, 67, 298 💬
281 Glutamatergic synapse 💬
 [2] CACNA1C, CACNA1D 💬 D01173 💬 Cilnidipine [1] 67 💬
282 Glycine, serine and threonine metabolism 💬
 [1] AOC3 💬 D08044 💬 Hydralazine [1] 67 💬
283 GnRH secretion 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00615 💬 Amlodipine [4] 13, 51, 67, 298 💬
284 GnRH secretion 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02914 💬 Amlodipine [4] 13, 51, 67, 298 💬
285 GnRH secretion 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07450 💬 Amlodipine [4] 13, 51, 67, 298 💬
286 GnRH secretion 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01173 💬 Cilnidipine [1] 67 💬
287 GnRH signaling pathway 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00615 💬 Amlodipine [4] 13, 51, 67, 298 💬
288 GnRH signaling pathway 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02914 💬 Amlodipine [4] 13, 51, 67, 298 💬
289 GnRH signaling pathway 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07450 💬 Amlodipine [4] 13, 51, 67, 298 💬
290 GnRH signaling pathway 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01173 💬 Cilnidipine [1] 67 💬
291 GnRH signaling pathway 💬
 [1] EGFR 💬 D11772 💬 Tesevatinib [1] 67 💬
292 GnRH signaling pathway 💬
 [1] SRC 💬 D03252 💬 Bosutinib [2]  2 , 67 💬
293 Growth hormone synthesis, secretion and action 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00615 💬 Amlodipine [4] 13, 51, 67, 298 💬
294 Growth hormone synthesis, secretion and action 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02914 💬 Amlodipine [4] 13, 51, 67, 298 💬
295 Growth hormone synthesis, secretion and action 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07450 💬 Amlodipine [4] 13, 51, 67, 298 💬
296 Growth hormone synthesis, secretion and action 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01173 💬 Cilnidipine [1] 67 💬
297 Growth hormone synthesis, secretion and action 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
298 Growth hormone synthesis, secretion and action 💬
 [1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
299 Growth hormone synthesis, secretion and action 💬
 [4] SSTR1, SSTR2, SSTR3, SSTR5 💬 D10147 💬 Pasireotide [3] 67, 74, 75 💬
300 Growth hormone synthesis, secretion and action 💬
 [4] SSTR1, SSTR2, SSTR3, SSTR5 💬 D07431 💬 Somatostatin [2] 67, 78 💬
301 Growth hormone synthesis, secretion and action 💬
 [1] SSTR2 💬 D00442 💬 Octreotide [7] 67, 75, 84, 85, 89, 193, 227 💬
302 Growth hormone synthesis, secretion and action 💬
 [1] SSTR2 💬 D06495 💬 Octreotide [7] 67, 75, 84, 85, 89, 193, 227 💬
303 Hepatitis B 💬
 [1] SRC 💬 D03252 💬 Bosutinib [2]  2 , 67 💬
304 Hepatitis C 💬
 [1] EGFR 💬 D11772 💬 Tesevatinib [1] 67 💬
305 Hepatocellular carcinoma 💬
 [1] EGFR 💬 D11772 💬 Tesevatinib [1] 67 💬
306 Hepatocellular carcinoma 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
307 Hepatocellular carcinoma 💬
 [1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
308 Herpes simplex virus 1 infection 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
309 Herpes simplex virus 1 infection 💬
 [1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
310 Herpes simplex virus 1 infection 💬
 [1] SRC 💬 D03252 💬 Bosutinib [2]  2 , 67 💬
311 HIF-1 signaling pathway 💬
 [2] EGFR, ERBB2 💬 D11772 💬 Tesevatinib [1] 67 💬
312 HIF-1 signaling pathway 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
313 HIF-1 signaling pathway 💬
 [1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
314 Human cytomegalovirus infection 💬
 [1] EGFR 💬 D11772 💬 Tesevatinib [1] 67 💬
315 Human cytomegalovirus infection 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
316 Human cytomegalovirus infection 💬
 [1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
317 Human cytomegalovirus infection 💬
 [1] SRC 💬 D03252 💬 Bosutinib [2]  2 , 67 💬
318 Human immunodeficiency virus 1 infection 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
319 Human immunodeficiency virus 1 infection 💬
 [1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
320 Human papillomavirus infection 💬
 [1] EGFR 💬 D11772 💬 Tesevatinib [1] 67 💬
321 Human papillomavirus infection 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
322 Human papillomavirus infection 💬
 [1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
323 Huntington disease 💬
 [1] CACNA1B 💬 D01173 💬 Cilnidipine [1] 67 💬
324 Huntington disease 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
325 Huntington disease 💬
 [1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
326 Huntington disease 💬
 [1] PPARG 💬 D00945 💬 Pioglitazone [17]  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
327 Huntington disease 💬
 [1] PPARG 💬 D08378 💬 Pioglitazone [17]  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
328 Hypertrophic cardiomyopathy 💬
 [1] ACE 💬 D08068 💬 Imidapril [1] 67 💬
329 Hypertrophic cardiomyopathy 💬
 [1] ACE 💬 D00362 💬 Lisinopril [7] 19, 46, 49, 66, 67, 113, 222 💬
330 Hypertrophic cardiomyopathy 💬
 [1] ACE 💬 D08131 💬 Lisinopril [7] 19, 46, 49, 66, 67, 113, 222 💬
331 Hypertrophic cardiomyopathy 💬
 [1] ACE 💬 D00421 💬 Ramipril [7] 46, 49, 66, 67, 113, 218, 257 💬
332 Hypertrophic cardiomyopathy 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00615 💬 Amlodipine [4] 13, 51, 67, 298 💬
333 Hypertrophic cardiomyopathy 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02914 💬 Amlodipine [4] 13, 51, 67, 298 💬
334 Hypertrophic cardiomyopathy 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07450 💬 Amlodipine [4] 13, 51, 67, 298 💬
335 Hypertrophic cardiomyopathy 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01173 💬 Cilnidipine [1] 67 💬
336 Hypertrophic cardiomyopathy 💬
 [2] PRKAA1, PRKAA2 💬 D00944 💬 Metformin [21]  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
337 Hypertrophic cardiomyopathy 💬
 [2] PRKAA1, PRKAA2 💬 D04966 💬 Metformin [21]  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
338 Inflammatory mediator regulation of TRP channels 💬
 [1] SRC 💬 D03252 💬 Bosutinib [2]  2 , 67 💬
339 Insulin resistance 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
340 Insulin resistance 💬
 [1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
341 Insulin resistance 💬
 [2] PRKAA1, PRKAA2 💬 D00944 💬 Metformin [21]  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
342 Insulin resistance 💬
 [2] PRKAA1, PRKAA2 💬 D04966 💬 Metformin [21]  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
343 Insulin secretion 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00615 💬 Amlodipine [4] 13, 51, 67, 298 💬
344 Insulin secretion 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02914 💬 Amlodipine [4] 13, 51, 67, 298 💬
345 Insulin secretion 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07450 💬 Amlodipine [4] 13, 51, 67, 298 💬
346 Insulin secretion 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01173 💬 Cilnidipine [1] 67 💬
347 Insulin signaling pathway 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
348 Insulin signaling pathway 💬
 [1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
349 Insulin signaling pathway 💬
 [2] PRKAA1, PRKAA2 💬 D00944 💬 Metformin [21]  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
350 Insulin signaling pathway 💬
 [2] PRKAA1, PRKAA2 💬 D04966 💬 Metformin [21]  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
351 JAK-STAT signaling pathway 💬
 [1] EGFR 💬 D11772 💬 Tesevatinib [1] 67 💬
352 JAK-STAT signaling pathway 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
353 JAK-STAT signaling pathway 💬
 [1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
354 Kaposi sarcoma-associated herpesvirus infection 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
355 Kaposi sarcoma-associated herpesvirus infection 💬
 [1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
356 Kaposi sarcoma-associated herpesvirus infection 💬
 [1] SRC 💬 D03252 💬 Bosutinib [2]  2 , 67 💬
357 Long-term potentiation 💬
 [1] CACNA1C 💬 D00615 💬 Amlodipine [4] 13, 51, 67, 298 💬
358 Long-term potentiation 💬
 [1] CACNA1C 💬 D02914 💬 Amlodipine [4] 13, 51, 67, 298 💬
359 Long-term potentiation 💬
 [1] CACNA1C 💬 D07450 💬 Amlodipine [4] 13, 51, 67, 298 💬
360 Long-term potentiation 💬
 [1] CACNA1C 💬 D01173 💬 Cilnidipine [1] 67 💬
361 Longevity regulating pathway 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
362 Longevity regulating pathway 💬
 [1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
363 Longevity regulating pathway 💬
 [1] PPARG 💬 D00945 💬 Pioglitazone [17]  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
364 Longevity regulating pathway 💬
 [1] PPARG 💬 D08378 💬 Pioglitazone [17]  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
365 Longevity regulating pathway 💬
 [2] PRKAA1, PRKAA2 💬 D00944 💬 Metformin [21]  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
366 Longevity regulating pathway 💬
 [2] PRKAA1, PRKAA2 💬 D04966 💬 Metformin [21]  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
367 Longevity regulating pathway - multiple species 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
368 Longevity regulating pathway - multiple species 💬
 [1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
369 Longevity regulating pathway - multiple species 💬
 [2] PRKAA1, PRKAA2 💬 D00944 💬 Metformin [21]  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
370 Longevity regulating pathway - multiple species 💬
 [2] PRKAA1, PRKAA2 💬 D04966 💬 Metformin [21]  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
371 MAPK signaling pathway 💬
 [5] CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01173 💬 Cilnidipine [1] 67 💬
372 MAPK signaling pathway 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00615 💬 Amlodipine [4] 13, 51, 67, 298 💬
373 MAPK signaling pathway 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02914 💬 Amlodipine [4] 13, 51, 67, 298 💬
374 MAPK signaling pathway 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07450 💬 Amlodipine [4] 13, 51, 67, 298 💬
375 MAPK signaling pathway 💬
 [4] EGFR, ERBB2, FLT4, KDR 💬 D11772 💬 Tesevatinib [1] 67 💬
376 Melanoma 💬
 [1] EGFR 💬 D11772 💬 Tesevatinib [1] 67 💬
377 Metabolic pathways 💬
 [1] AOC3 💬 D08044 💬 Hydralazine [1] 67 💬
378 Metabolic pathways 💬
 [1] HMGCR 💬 D00893 💬 Pravastatin [9] 13, 46, 49, 67, 79, 96, 164, 265, 333 💬
379 Metabolic pathways 💬
 [1] HMGCR 💬 D08410 💬 Pravastatin [9] 13, 46, 49, 67, 79, 96, 164, 265, 333 💬
380 Metabolic pathways 💬
 [1] UGCG 💬 D11633 💬 Venglustat [3]  6 , 19, 67 💬
381 MicroRNAs in cancer 💬
 [1] ABL1 💬 D03252 💬 Bosutinib [2]  2 , 67 💬
382 MicroRNAs in cancer 💬
 [2] EGFR, ERBB2 💬 D11772 💬 Tesevatinib [1] 67 💬
383 MicroRNAs in cancer 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
384 MicroRNAs in cancer 💬
 [1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
385 Mitophagy - animal 💬
 [1] SRC 💬 D03252 💬 Bosutinib [2]  2 , 67 💬
386 Morphine addiction 💬
 [1] CACNA1B 💬 D01173 💬 Cilnidipine [1] 67 💬
387 mTOR signaling pathway 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
388 mTOR signaling pathway 💬
 [1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
389 mTOR signaling pathway 💬
 [2] PRKAA1, PRKAA2 💬 D00944 💬 Metformin [21]  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
390 mTOR signaling pathway 💬
 [2] PRKAA1, PRKAA2 💬 D04966 💬 Metformin [21]  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
391 Neuroactive ligand-receptor interaction 💬
 [3] ADRA1A, ADRA1B, ADRA1D 💬 D00608 💬 Doxazosin [2] 57, 67 💬
392 Neuroactive ligand-receptor interaction 💬
 [3] ADRA1A, ADRA1B, ADRA1D 💬 D07874 💬 Doxazosin [2] 57, 67 💬
393 Neuroactive ligand-receptor interaction 💬
 [1] ADRB1 💬 D00634 💬 Bisoprolol [3] 67, 86, 113 💬
394 Neuroactive ligand-receptor interaction 💬
 [1] ADRB1 💬 D02342 💬 Bisoprolol [3] 67, 86, 113 💬
395 Neuroactive ligand-receptor interaction 💬
 [1] AGTR1 💬 D00522 💬 Candesartan [2] 58, 67 💬
396 Neuroactive ligand-receptor interaction 💬
 [1] AGTR1 💬 D00522 💬 Candesartan cilexetil [1] 67 💬
397 Neuroactive ligand-receptor interaction 💬
 [1] AGTR1 💬 D00626 💬 Candesartan cilexetil [1] 67 💬
398 Neuroactive ligand-receptor interaction 💬
 [1] AGTR1 💬 D00357 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
399 Neuroactive ligand-receptor interaction 💬
 [1] AGTR1 💬 D08146 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
400 Neuroactive ligand-receptor interaction 💬
 [1] AGTR1 💬 D00627 💬 Telmisartan [2] 66, 67 💬
401 Neuroactive ligand-receptor interaction 💬
 [1] AVPR2 💬 D04752 💬 Lixivaptan [1] 67 💬
402 Neuroactive ligand-receptor interaction 💬
 [1] AVPR2 💬 D01213 💬 Tolvaptan [3] 67, 72, 225 💬
403 Neuroactive ligand-receptor interaction 💬
 [5] SSTR1, SSTR2, SSTR3, SSTR4, SSTR5 💬 D07431 💬 Somatostatin [2] 67, 78 💬
404 Neuroactive ligand-receptor interaction 💬
 [4] SSTR1, SSTR2, SSTR3, SSTR5 💬 D10147 💬 Pasireotide [3] 67, 74, 75 💬
405 Neuroactive ligand-receptor interaction 💬
 [1] SSTR2 💬 D00442 💬 Octreotide [7] 67, 75, 84, 85, 89, 193, 227 💬
406 Neuroactive ligand-receptor interaction 💬
 [1] SSTR2 💬 D06495 💬 Octreotide [7] 67, 75, 84, 85, 89, 193, 227 💬
407 Neurotrophin signaling pathway 💬
 [1] ABL1 💬 D03252 💬 Bosutinib [2]  2 , 67 💬
408 Neutrophil extracellular trap formation 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
409 Neutrophil extracellular trap formation 💬
 [1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
410 Neutrophil extracellular trap formation 💬
 [1] SRC 💬 D03252 💬 Bosutinib [2]  2 , 67 💬
411 Nicotine addiction 💬
 [1] CACNA1B 💬 D01173 💬 Cilnidipine [1] 67 💬
412 Non-alcoholic fatty liver disease 💬
 [2] PRKAA1, PRKAA2 💬 D00944 💬 Metformin [21]  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
413 Non-alcoholic fatty liver disease 💬
 [2] PRKAA1, PRKAA2 💬 D04966 💬 Metformin [21]  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
414 Non-small cell lung cancer 💬
 [2] EGFR, ERBB2 💬 D11772 💬 Tesevatinib [1] 67 💬
415 Osteoclast differentiation 💬
 [1] PPARG 💬 D00945 💬 Pioglitazone [17]  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
416 Osteoclast differentiation 💬
 [1] PPARG 💬 D08378 💬 Pioglitazone [17]  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
417 Oxytocin signaling pathway 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00615 💬 Amlodipine [4] 13, 51, 67, 298 💬
418 Oxytocin signaling pathway 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02914 💬 Amlodipine [4] 13, 51, 67, 298 💬
419 Oxytocin signaling pathway 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07450 💬 Amlodipine [4] 13, 51, 67, 298 💬
420 Oxytocin signaling pathway 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01173 💬 Cilnidipine [1] 67 💬
421 Oxytocin signaling pathway 💬
 [1] EGFR 💬 D11772 💬 Tesevatinib [1] 67 💬
422 Oxytocin signaling pathway 💬
 [2] PRKAA1, PRKAA2 💬 D00944 💬 Metformin [21]  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
423 Oxytocin signaling pathway 💬
 [2] PRKAA1, PRKAA2 💬 D04966 💬 Metformin [21]  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
424 Oxytocin signaling pathway 💬
 [1] SRC 💬 D03252 💬 Bosutinib [2]  2 , 67 💬
425 Pancreatic cancer 💬
 [2] EGFR, ERBB2 💬 D11772 💬 Tesevatinib [1] 67 💬
426 Pancreatic cancer 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
427 Pancreatic cancer 💬
 [1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
428 Parathyroid hormone synthesis, secretion and action 💬
 [1] EGFR 💬 D11772 💬 Tesevatinib [1] 67 💬
429 Pathogenic Escherichia coli infection 💬
 [2] ABL1, SRC 💬 D03252 💬 Bosutinib [2]  2 , 67 💬
430 Pathways in cancer 💬
 [1] ABL1 💬 D03252 💬 Bosutinib [2]  2 , 67 💬
431 Pathways in cancer 💬
 [1] AGTR1 💬 D00522 💬 Candesartan [2] 58, 67 💬
432 Pathways in cancer 💬
 [1] AGTR1 💬 D00522 💬 Candesartan cilexetil [1] 67 💬
433 Pathways in cancer 💬
 [1] AGTR1 💬 D00626 💬 Candesartan cilexetil [1] 67 💬
434 Pathways in cancer 💬
 [1] AGTR1 💬 D00357 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
435 Pathways in cancer 💬
 [1] AGTR1 💬 D08146 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
436 Pathways in cancer 💬
 [1] AGTR1 💬 D00627 💬 Telmisartan [2] 66, 67 💬
437 Pathways in cancer 💬
 [3] EGFR, ERBB2, FLT4 💬 D11772 💬 Tesevatinib [1] 67 💬
438 Pathways in cancer 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
439 Pathways in cancer 💬
 [1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
440 Pathways in cancer 💬
 [1] PPARG 💬 D00945 💬 Pioglitazone [17]  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
441 Pathways in cancer 💬
 [1] PPARG 💬 D08378 💬 Pioglitazone [17]  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
442 Pathways of neurodegeneration - multiple diseases 💬
 [5] CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01173 💬 Cilnidipine [1] 67 💬
443 Pathways of neurodegeneration - multiple diseases 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00615 💬 Amlodipine [4] 13, 51, 67, 298 💬
444 Pathways of neurodegeneration - multiple diseases 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02914 💬 Amlodipine [4] 13, 51, 67, 298 💬
445 Pathways of neurodegeneration - multiple diseases 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07450 💬 Amlodipine [4] 13, 51, 67, 298 💬
446 Pathways of neurodegeneration - multiple diseases 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
447 Pathways of neurodegeneration - multiple diseases 💬
 [1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
448 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 [1] EGFR 💬 D11772 💬 Tesevatinib [1] 67 💬
449 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
450 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 [1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
451 Phenylalanine metabolism 💬
 [1] AOC3 💬 D08044 💬 Hydralazine [1] 67 💬
452 Phospholipase D signaling pathway 💬
 [1] AGTR1 💬 D00522 💬 Candesartan [2] 58, 67 💬
453 Phospholipase D signaling pathway 💬
 [1] AGTR1 💬 D00522 💬 Candesartan cilexetil [1] 67 💬
454 Phospholipase D signaling pathway 💬
 [1] AGTR1 💬 D00626 💬 Candesartan cilexetil [1] 67 💬
455 Phospholipase D signaling pathway 💬
 [1] AGTR1 💬 D00357 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
456 Phospholipase D signaling pathway 💬
 [1] AGTR1 💬 D08146 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
457 Phospholipase D signaling pathway 💬
 [1] AGTR1 💬 D00627 💬 Telmisartan [2] 66, 67 💬
458 Phospholipase D signaling pathway 💬
 [1] AVPR2 💬 D04752 💬 Lixivaptan [1] 67 💬
459 Phospholipase D signaling pathway 💬
 [1] AVPR2 💬 D01213 💬 Tolvaptan [3] 67, 72, 225 💬
460 Phospholipase D signaling pathway 💬
 [1] EGFR 💬 D11772 💬 Tesevatinib [1] 67 💬
461 Phospholipase D signaling pathway 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
462 Phospholipase D signaling pathway 💬
 [1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
463 PI3K-Akt signaling pathway 💬
 [4] EGFR, ERBB2, FLT4, KDR 💬 D11772 💬 Tesevatinib [1] 67 💬
464 PI3K-Akt signaling pathway 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
465 PI3K-Akt signaling pathway 💬
 [1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
466 PI3K-Akt signaling pathway 💬
 [2] PRKAA1, PRKAA2 💬 D00944 💬 Metformin [21]  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
467 PI3K-Akt signaling pathway 💬
 [2] PRKAA1, PRKAA2 💬 D04966 💬 Metformin [21]  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
468 Platelet activation 💬
 [1] SRC 💬 D03252 💬 Bosutinib [2]  2 , 67 💬
469 Platinum drug resistance 💬
 [1] ERBB2 💬 D11772 💬 Tesevatinib [1] 67 💬
470 PPAR signaling pathway 💬
 [1] PPARG 💬 D00945 💬 Pioglitazone [17]  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
471 PPAR signaling pathway 💬
 [1] PPARG 💬 D08378 💬 Pioglitazone [17]  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
472 Prion disease 💬
 [5] CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01173 💬 Cilnidipine [1] 67 💬
473 Prion disease 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00615 💬 Amlodipine [4] 13, 51, 67, 298 💬
474 Prion disease 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02914 💬 Amlodipine [4] 13, 51, 67, 298 💬
475 Prion disease 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07450 💬 Amlodipine [4] 13, 51, 67, 298 💬
476 Prolactin signaling pathway 💬
 [1] SRC 💬 D03252 💬 Bosutinib [2]  2 , 67 💬
477 Prostate cancer 💬
 [2] EGFR, ERBB2 💬 D11772 💬 Tesevatinib [1] 67 💬
478 Prostate cancer 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
479 Prostate cancer 💬
 [1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
480 Proteoglycans in cancer 💬
 [3] EGFR, ERBB2, KDR 💬 D11772 💬 Tesevatinib [1] 67 💬
481 Proteoglycans in cancer 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
482 Proteoglycans in cancer 💬
 [1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
483 Proteoglycans in cancer 💬
 [1] SRC 💬 D03252 💬 Bosutinib [2]  2 , 67 💬
484 Rap1 signaling pathway 💬
 [3] EGFR, FLT4, KDR 💬 D11772 💬 Tesevatinib [1] 67 💬
485 Rap1 signaling pathway 💬
 [1] SRC 💬 D03252 💬 Bosutinib [2]  2 , 67 💬
486 Ras signaling pathway 💬
 [1] ABL1 💬 D03252 💬 Bosutinib [2]  2 , 67 💬
487 Ras signaling pathway 💬
 [3] EGFR, FLT4, KDR 💬 D11772 💬 Tesevatinib [1] 67 💬
488 Regulation of actin cytoskeleton 💬
 [1] EGFR 💬 D11772 💬 Tesevatinib [1] 67 💬
489 Regulation of actin cytoskeleton 💬
 [1] SRC 💬 D03252 💬 Bosutinib [2]  2 , 67 💬
490 Regulation of lipolysis in adipocytes 💬
 [1] ADRB1 💬 D00634 💬 Bisoprolol [3] 67, 86, 113 💬
491 Regulation of lipolysis in adipocytes 💬
 [1] ADRB1 💬 D02342 💬 Bisoprolol [3] 67, 86, 113 💬
492 Relaxin signaling pathway 💬
 [1] EGFR 💬 D11772 💬 Tesevatinib [1] 67 💬
493 Relaxin signaling pathway 💬
 [1] SRC 💬 D03252 💬 Bosutinib [2]  2 , 67 💬
494 Renin secretion 💬
 [1] ACE 💬 D08068 💬 Imidapril [1] 67 💬
495 Renin secretion 💬
 [1] ACE 💬 D00362 💬 Lisinopril [7] 19, 46, 49, 66, 67, 113, 222 💬
496 Renin secretion 💬
 [1] ACE 💬 D08131 💬 Lisinopril [7] 19, 46, 49, 66, 67, 113, 222 💬
497 Renin secretion 💬
 [1] ACE 💬 D00421 💬 Ramipril [7] 46, 49, 66, 67, 113, 218, 257 💬
498 Renin secretion 💬
 [1] ADRB1 💬 D00634 💬 Bisoprolol [3] 67, 86, 113 💬
499 Renin secretion 💬
 [1] ADRB1 💬 D02342 💬 Bisoprolol [3] 67, 86, 113 💬
500 Renin secretion 💬
 [1] AGTR1 💬 D00522 💬 Candesartan [2] 58, 67 💬
501 Renin secretion 💬
 [1] AGTR1 💬 D00522 💬 Candesartan cilexetil [1] 67 💬
502 Renin secretion 💬
 [1] AGTR1 💬 D00626 💬 Candesartan cilexetil [1] 67 💬
503 Renin secretion 💬
 [1] AGTR1 💬 D00357 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
504 Renin secretion 💬
 [1] AGTR1 💬 D08146 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
505 Renin secretion 💬
 [1] AGTR1 💬 D00627 💬 Telmisartan [2] 66, 67 💬
506 Renin secretion 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00615 💬 Amlodipine [4] 13, 51, 67, 298 💬
507 Renin secretion 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02914 💬 Amlodipine [4] 13, 51, 67, 298 💬
508 Renin secretion 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07450 💬 Amlodipine [4] 13, 51, 67, 298 💬
509 Renin secretion 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01173 💬 Cilnidipine [1] 67 💬
510 Renin-angiotensin system 💬
 [1] ACE 💬 D08068 💬 Imidapril [1] 67 💬
511 Renin-angiotensin system 💬
 [1] ACE 💬 D00362 💬 Lisinopril [7] 19, 46, 49, 66, 67, 113, 222 💬
512 Renin-angiotensin system 💬
 [1] ACE 💬 D08131 💬 Lisinopril [7] 19, 46, 49, 66, 67, 113, 222 💬
513 Renin-angiotensin system 💬
 [1] ACE 💬 D00421 💬 Ramipril [7] 46, 49, 66, 67, 113, 218, 257 💬
514 Renin-angiotensin system 💬
 [1] AGTR1 💬 D00522 💬 Candesartan [2] 58, 67 💬
515 Renin-angiotensin system 💬
 [1] AGTR1 💬 D00522 💬 Candesartan cilexetil [1] 67 💬
516 Renin-angiotensin system 💬
 [1] AGTR1 💬 D00626 💬 Candesartan cilexetil [1] 67 💬
517 Renin-angiotensin system 💬
 [1] AGTR1 💬 D00357 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
518 Renin-angiotensin system 💬
 [1] AGTR1 💬 D08146 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
519 Renin-angiotensin system 💬
 [1] AGTR1 💬 D00627 💬 Telmisartan [2] 66, 67 💬
520 Retrograde endocannabinoid signaling 💬
 [5] CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01173 💬 Cilnidipine [1] 67 💬
521 Retrograde endocannabinoid signaling 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00615 💬 Amlodipine [4] 13, 51, 67, 298 💬
522 Retrograde endocannabinoid signaling 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02914 💬 Amlodipine [4] 13, 51, 67, 298 💬
523 Retrograde endocannabinoid signaling 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07450 💬 Amlodipine [4] 13, 51, 67, 298 💬
524 Salivary secretion 💬
 [3] ADRA1A, ADRA1B, ADRA1D 💬 D00608 💬 Doxazosin [2] 57, 67 💬
525 Salivary secretion 💬
 [3] ADRA1A, ADRA1B, ADRA1D 💬 D07874 💬 Doxazosin [2] 57, 67 💬
526 Salivary secretion 💬
 [1] ADRB1 💬 D00634 💬 Bisoprolol [3] 67, 86, 113 💬
527 Salivary secretion 💬
 [1] ADRB1 💬 D02342 💬 Bisoprolol [3] 67, 86, 113 💬
528 Serotonergic synapse 💬
 [5] CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01173 💬 Cilnidipine [1] 67 💬
529 Serotonergic synapse 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00615 💬 Amlodipine [4] 13, 51, 67, 298 💬
530 Serotonergic synapse 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02914 💬 Amlodipine [4] 13, 51, 67, 298 💬
531 Serotonergic synapse 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07450 💬 Amlodipine [4] 13, 51, 67, 298 💬
532 Shigellosis 💬
 [1] EGFR 💬 D11772 💬 Tesevatinib [1] 67 💬
533 Shigellosis 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
534 Shigellosis 💬
 [1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
535 Shigellosis 💬
 [1] SRC 💬 D03252 💬 Bosutinib [2]  2 , 67 💬
536 Sphingolipid metabolism 💬
 [1] UGCG 💬 D11633 💬 Venglustat [3]  6 , 19, 67 💬
537 Spinocerebellar ataxia 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
538 Spinocerebellar ataxia 💬
 [1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
539 Synaptic vesicle cycle 💬
 [1] CACNA1B 💬 D01173 💬 Cilnidipine [1] 67 💬
540 Taste transduction 💬
 [1] CACNA1C 💬 D00615 💬 Amlodipine [4] 13, 51, 67, 298 💬
541 Taste transduction 💬
 [1] CACNA1C 💬 D02914 💬 Amlodipine [4] 13, 51, 67, 298 💬
542 Taste transduction 💬
 [1] CACNA1C 💬 D07450 💬 Amlodipine [4] 13, 51, 67, 298 💬
543 Taste transduction 💬
 [1] CACNA1C 💬 D01173 💬 Cilnidipine [1] 67 💬
544 Taste transduction 💬
 [2] TAS1R2, TAS1R3 💬 D02381 💬 Aspartame [5]  6 , 13, 67, 86, 230 💬
545 Terpenoid backbone biosynthesis 💬
 [1] HMGCR 💬 D00893 💬 Pravastatin [9] 13, 46, 49, 67, 79, 96, 164, 265, 333 💬
546 Terpenoid backbone biosynthesis 💬
 [1] HMGCR 💬 D08410 💬 Pravastatin [9] 13, 46, 49, 67, 79, 96, 164, 265, 333 💬
547 Th17 cell differentiation 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
548 Th17 cell differentiation 💬
 [1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
549 Thermogenesis 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
550 Thermogenesis 💬
 [1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
551 Thermogenesis 💬
 [1] PPARG 💬 D00945 💬 Pioglitazone [17]  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
552 Thermogenesis 💬
 [1] PPARG 💬 D08378 💬 Pioglitazone [17]  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
553 Thermogenesis 💬
 [2] PRKAA1, PRKAA2 💬 D00944 💬 Metformin [21]  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
554 Thermogenesis 💬
 [2] PRKAA1, PRKAA2 💬 D04966 💬 Metformin [21]  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
555 Thyroid cancer 💬
 [1] PPARG 💬 D00945 💬 Pioglitazone [17]  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
556 Thyroid cancer 💬
 [1] PPARG 💬 D08378 💬 Pioglitazone [17]  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
557 Thyroid hormone signaling pathway 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
558 Thyroid hormone signaling pathway 💬
 [1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
559 Thyroid hormone signaling pathway 💬
 [1] SRC 💬 D03252 💬 Bosutinib [2]  2 , 67 💬
560 Tight junction 💬
 [1] CACNA1D 💬 D00615 💬 Amlodipine [4] 13, 51, 67, 298 💬
561 Tight junction 💬
 [1] CACNA1D 💬 D02914 💬 Amlodipine [4] 13, 51, 67, 298 💬
562 Tight junction 💬
 [1] CACNA1D 💬 D07450 💬 Amlodipine [4] 13, 51, 67, 298 💬
563 Tight junction 💬
 [1] CACNA1D 💬 D01173 💬 Cilnidipine [1] 67 💬
564 Tight junction 💬
 [1] ERBB2 💬 D11772 💬 Tesevatinib [1] 67 💬
565 Tight junction 💬
 [2] PRKAA1, PRKAA2 💬 D00944 💬 Metformin [21]  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
566 Tight junction 💬
 [2] PRKAA1, PRKAA2 💬 D04966 💬 Metformin [21]  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
567 Tight junction 💬
 [1] SRC 💬 D03252 💬 Bosutinib [2]  2 , 67 💬
568 Transcriptional misregulation in cancer 💬
 [1] PPARG 💬 D00945 💬 Pioglitazone [17]  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
569 Transcriptional misregulation in cancer 💬
 [1] PPARG 💬 D08378 💬 Pioglitazone [17]  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
570 Tuberculosis 💬
 [1] SRC 💬 D03252 💬 Bosutinib [2]  2 , 67 💬
571 Type II diabetes mellitus 💬
 [3] CACNA1B, CACNA1C, CACNA1D 💬 D01173 💬 Cilnidipine [1] 67 💬
572 Type II diabetes mellitus 💬
 [2] CACNA1C, CACNA1D 💬 D00615 💬 Amlodipine [4] 13, 51, 67, 298 💬
573 Type II diabetes mellitus 💬
 [2] CACNA1C, CACNA1D 💬 D02914 💬 Amlodipine [4] 13, 51, 67, 298 💬
574 Type II diabetes mellitus 💬
 [2] CACNA1C, CACNA1D 💬 D07450 💬 Amlodipine [4] 13, 51, 67, 298 💬
575 Type II diabetes mellitus 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
576 Type II diabetes mellitus 💬
 [1] MTOR 💬 D00753 💬 Sirolimus [40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
577 Tyrosine metabolism 💬
 [1] AOC3 💬 D08044 💬 Hydralazine [1] 67 💬
578 Vascular smooth muscle contraction 💬
 [3] ADRA1A, ADRA1B, ADRA1D 💬 D00608 💬 Doxazosin [2] 57, 67 💬
579 Vascular smooth muscle contraction 💬
 [3] ADRA1A, ADRA1B, ADRA1D 💬 D07874 💬 Doxazosin [2] 57, 67 💬
580 Vascular smooth muscle contraction 💬
 [1] AGTR1 💬 D00522 💬 Candesartan [2] 58, 67 💬
581 Vascular smooth muscle contraction 💬
 [1] AGTR1 💬 D00522 💬 Candesartan cilexetil [1] 67 💬
582 Vascular smooth muscle contraction 💬
 [1] AGTR1 💬 D00626 💬 Candesartan cilexetil [1] 67 💬
583 Vascular smooth muscle contraction 💬
 [1] AGTR1 💬 D00357 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
584 Vascular smooth muscle contraction 💬
 [1] AGTR1 💬 D08146 💬 Losartan [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
585 Vascular smooth muscle contraction 💬
 [1] AGTR1 💬 D00627 💬 Telmisartan [2] 66, 67 💬
586 Vascular smooth muscle contraction 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00615 💬 Amlodipine [4] 13, 51, 67, 298 💬
587 Vascular smooth muscle contraction 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02914 💬 Amlodipine [4] 13, 51, 67, 298 💬
588 Vascular smooth muscle contraction 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D07450 💬 Amlodipine [4] 13, 51, 67, 298 💬
589 Vascular smooth muscle contraction 💬
 [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01173 💬 Cilnidipine [1] 67 💬
590 Vasopressin-regulated water reabsorption 💬
 [1] AVPR2 💬 D04752 💬 Lixivaptan [1] 67 💬
591 Vasopressin-regulated water reabsorption 💬
 [1] AVPR2 💬 D01213 💬 Tolvaptan [3] 67, 72, 225 💬
592 VEGF signaling pathway 💬
 [1] KDR 💬 D11772 💬 Tesevatinib [1] 67 💬
593 VEGF signaling pathway 💬
 [1] SRC 💬 D03252 💬 Bosutinib [2]  2 , 67 💬
594 Viral carcinogenesis 💬
 [1] SRC 💬 D03252 💬 Bosutinib [2]  2 , 67 💬
595 Viral myocarditis 💬
 [1] ABL1 💬 D03252 💬 Bosutinib [2]  2 , 67 💬
596 Yersinia infection 💬
 [1] SRC 💬 D03252 💬 Bosutinib [2]  2 , 67 💬

Back to top